CAS: 76568-02-0; Flosequinan

该化合物是一种氟己醇衍生物,其特点是独特的硫基和甲基替代成分,该化合物的结构特征,包括电子脱色氟组和硫基分子,有助于其在制药或农用化学中间体中的潜在再活性和实用性;甲烷硫基集团的存在可能提高溶性并改变电子特性,使之适合进一步功能化或成为七环合成的建筑块;其明确界定的分子结构允许在药用化学中精确应用,特别是在生物活性分子的开发中.该化合物的稳定性和纯度对于研究和工业环境中的可复制结果至关重要.

结构式图片

相似化合物

76561-14-3 591781-26-9 2169907-32-6

MSDS等安全信息

    上下游产品

    CAS号154639-75-5 1-[4-fluoro-2-(... | CAS号77-78-1 硫酸二甲酯 | CAS号76561-14-3 7-fluoro-3-meth... | CAS号122-51-0 原甲酸三乙酯 | CAS号321-50-6 7-氟-2H-3,1-苯并噁嗪... | CAS号2252-51-9 2-氯-4-氟苯甲酸 | CAS号128992-62-1 4-氟-2-(甲基氨基)苯甲酸 | CAS号97927-92-9 7-fluoro-2-meth...

    合成工艺路线路线简述

    • 合成目标产物 Flosequinan 主要起始原料 7-Fluoro-1-H-Benzo[d][1,3]Oxazine-2,4-Dione
    • (文献来源)合成步骤主要原料 7-Fluoro-1-H-Benzo[d][1,3]Oxazine-2,4-Dione
    📜1-(4-Fluoro-2-Methylaminophenyl)-2-Methylsulfinylethanone置于sodium Hydroxide,甲酸,乙酸酐体系中,用 水,甲苯 作为反应溶剂,化学反应生成 氟司喹南
    参考文献:Process For The Preparation Of 1-Methyl-3-Methylthio-4-Quinolone And The
    标题:Process For The Preparation Of 1-Methyl-3-Methylthio-4-Quinolone And The
    摘要:一种制备化合物i的过程,其中n=0,1或2,包括将化合物ii环化的步骤,其中n=0,1或2.环化可以在有机或无机碱的存在下或在40-160摄氏度范围内热处理的条件下进行.化合物ii及其某些类似物被披露为心血管药物.

    海关参考信息

    专利信息


    专利号:US-10925977-B2
    优先权日:2006-10-05
    标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
    发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
    权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
    摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

    专利号:US-6730790-B2
    优先权日:2002-03-01
    标 题:Chlorinated heterocyclic compounds and methods of synthesis
    发明人:KWIATKOWSKI STEFAN; GOLINSKI MIROSLAW
    权利人:R T ALAMO VENTURES I LLC
    摘要:Compositions of the present invention comprise chlorinated heterocyclic compounds, including racemic monochloroflosequinan, purified enantiomers of monochloroflosequinan and the sulfone derivative of monochloroflosequinan. The methods of the present invention comprise the synthesis of racemic monochloroflosequinan and derivatives thereof, including the sulfone derivative. Intermediates in the synthesis are also provided. The methods further comprise the synthesis of enantiomers of monochloroflosequinan.

    专利号:US-7034040-B2
    优先权日:2002-03-01
    标题:Fluorinated heterocyclic compounds and methods of synthesis
    发明人:KWIATKOWSKI STEFAN; GOLINSKI MIROSLAW
    权利人:R T ALAMO VENTURES I
    摘要:Compositions of the present invention comprise fluorinated heterocyclic compounds, including monofluoroflosequinan and difluoroflosequinan. The methods of the present invention comprise the synthesis of monofluoroflosequinan and difluoroflosequinan.

    专利号:US-7045627-B2
    优先权日:2002-03-01
    标题:Dichlorinated heterocyclic compounds and methods of synthesis
    发明人:KWIATKOWSKI STEFAN; GOLINSKI MIROSLAW
    权利人:R T ALAMO VENTURES I LLC
    摘要:Compositions of the present invention comprise dichlorinated heterocyclic compounds, including dichloroflosequinan. The methods of the present invention also comprise the synthesis of dichloroflosequinan.

    专利号:US-6872831-B2
    优先权日:2002-03-01
    标题:Carboxylated heterocyclic compounds and methods of synthesis
    发明人:KWIATKOWSKI STEFAN; GOLINSKI MIROSLAW
    权利人:R T ALAMO VENTURES I LLC
    摘要:Compositions of the present invention comprise carboxylated heterocyclic compounds, including carboxyflosequinan. The methods of the present invention also comprise the synthesis of carboxyflosequinan.

    专利号:US-7084275-B2
    优先权日:2001-10-25
    标题 :Stereospecific enrichment of heterocyclic enantiomers
    发明人:KWIATKOWSKI STEFAN; GOLINSKI MIROSLAW; KUPPER JOSEPH
    权利人:R T ALAMO VENTURES I LLC
    摘要:The present invention describes methods for the stereoselective synthesis of heterocyclic enantiomers. The methods of the present invention incorporate the stereo-preferred oxidation of quinolone thiomethyl intermediates by optically active camphor based oxaziridines to provide R(+) or S(−) quinolone methylsulfinyl derivatives.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Yano M, Kohno M, Yamamoto T, Hisaoka T, Tanigawa T, Ono K, Lee B, Konishi M, Matsuzaki M. Effects of balanced vasodilator, flosequinan, on aortic impedance in failing heart. J Cardiovasc Pharmacol. 1998 Sep;32(3):466-70.
    5: Kessler PD, Packer M, Medina N, Yushak M. Cumulative hemodynamic response to short-term treatment with flosequinan (BTS 49465), a new direct-acting vasodilator drug, in severe chronic congestive heart failure. J Cardiovasc Pharmacol. 1988 Jul;12(1):6-11.
    10: Elborn JS, Riley M, Stanford CF, Nicholls DP. The effects of flosequinan on submaximal exercise in patients with chronic cardiac failure. Br J Clin Pharmacol. 1990 May;29(5):519-24.

    合成参考文献


    参考文献:10.1007/bf02627961
    摘要:Wiklund I, Waagstein F, Swedberg K, Hjalmarsson A. Quality of life on treatment with metoprolol in dilated cardiomyopathy: results from the MDC trial. Metoprolol in Dilated Cardiomyopathy trial. Cardiovasc Drugs Ther. 1996 Jul;10(3):361–8. doi: 10.1007/bf02627961.
    参考文献:10.2165/00003495-199651030-00001
    摘要:Bonarjee VV, Dickstein K. Novel drugs and current therapeutic approaches in the treatment of heart failure. Drugs. 1996 Mar;51(3):347–58. doi: 10.2165/00003495-199651030-00001.
    参考文献:10.1007/s11886-002-0051-3
    摘要:Lisman KA, Stetson SJ, Koerner MM, Farmer JA, Torre-Amione G. The role of inflammation in the pathogenesis of heart failure. Curr Cardiol Rep. 2002 May;4(3):200–5. doi: 10.1007/s11886-002-0051-3.
    参考文献:10.1007/bf01744866
    摘要:Hori M, Sato H, Ozaki H, Inoue M, Naka M, Fukunami M, Fukushima M, Kunisada K. Effect of flosequinan on exercise capacity and cardiac function in patients with chronic mild heart failure: a double-blind placebo-controlled study. Heart Vessels. 1992;7(3):133–40. doi: 10.1007/bf01744866.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知